Bromelain and spike protein research has examined how this group of proteolytic enzymes may interact with proteins associated with SARS-CoV-2, including the viral spike protein. Bromelain is a mixture of enzymes naturally found in pineapple and has been investigated for its proteolytic, anti-inflammatory and other biological activities.
Laboratory and preclinical studies have explored whether bromelain can influence spike protein, ACE2 and TMPRSS2-related mechanisms involved in SARS-CoV-2 infection. Some experimental research has reported effects on viral proteins and infection-related pathways, while other publications have discussed bromelain as part of broader research protocols involving compounds such as nattokinase and curcumin.
However, laboratory findings should not be interpreted as proof that bromelain can prevent or treat COVID-19 or remove spike protein from the human body. Human clinical evidence remains an important area of research. This page reviews published studies and explains the current evidence, proposed mechanisms and limitations of research on bromelain and spike protein.
Bromelain is a group of protein-digesting enzymes naturally found in pineapple, particularly in the stem and fruit. It has been studied for its biological activity and potential applications related to inflammation, digestion, and other areas of health. Research into bromelain is ongoing, including laboratory studies exploring its interaction with proteins.
Bromelain is naturally present in the pineapple plant (Ananascomosus). Commercial bromelain is commonly obtained from pineapple stems, which contain a relatively high concentration of these enzymes.
Bromelain is generally obtained from pineapple plant material through processes such as pressing, filtration, purification, and concentration. Manufacturers may further process and standardize the enzyme preparation for use in dietary supplements and research.
Pineapple has traditionally been consumed as a food, while bromelain preparations have been used in various wellness applications. Modern research has investigated bromelain for areas including digestion, inflammation, and recovery, although evidence varies depending on the specific use.
Researchers study bromelain because of its proteolytic activity, meaning it can break down proteins under certain conditions. Laboratory and clinical researchhasexplored its potential biological effects,whileadditionalstudies are needed to understand itspossible applicationsand effectiveness in specific health conditions.
Below are key published studies that explore bromelain in relation to SARS-CoV-2, spike protein, inflammation, and related biological mechanisms.
Year: 2023
Year: 2023
Due to its biological and proteolytic characteristics, which offer a number of potential mechanisms for study, bromelain has drawn attention from researchers. These characteristics may be relevant to research on viral proteins, inflammation, and immunological responses, according to researchers.
It is possible for proteins to be digested through the cysteine proteases that are present in the bromelain enzymes. It means that in a laboratory setting, researchers will study whether the bromelain enzymes and their components react with certain proteins.
Bromelain was looked into as a possible competitive inhibitor of interactions between the ACE2 receptor and the SARS-CoV-2 spike protein in a recent in-silico analysis. Molecular docking and simulation techniques were applied to a number of SARS-CoV-2 variants. Although computational calculations do not prove that bromelain has the same impact in the human body, these findings are helpful for generating alternatives.
Another important area of bromelain research is inflammation. Its impact on signalling pathways and inflammatory mediators has been studied in the lab. Although results vary depending on the experimental model and conditions, a thorough evaluation of experimental research revealed effects involving cytokines such as TNF-α, IL-1β, and IL-6.
Researchers are curious about whether bromelain's biological effects could have wider implications because inflammatory reactions can accompany a variety of illnesses and other disorders. However, a laboratory study's anti-inflammatory efficacy shouldn't be taken at face value as a COVID-19 or post-viral treatment.
The potential immunomodulatory effects of bromelain have also been studied. Although reviews discuss interactions with immunological and inflammatory processes, the exact pathways are still unclear.
Therefore, rather than discussing bromelain as a proven antiviral treatment, scientific studies address it as a topic for further research. To find out if laboratory observations result in significant clinical results, more controlled research is required.
There is occasionally discussion of bromelain and other proteolytic enzymes in connection with suggested treatments for long-term or post-COVID problems. Discussion of a potential biological mechanism, however, isnot the same asproof of clinical efficacy.
No evidence shows that taking bromelain orally can remove the residual spike proteins from the body or treat Long COVID. Such hypotheses require clinical studies involving specific patient groups with clear outcomes, controls, and proper follow-up.
A number of explanations have been put forth for why bromelain may require additional study in relation to spike proteins. Instead of being clinically proven, the majority continue to be theoretical or experimental.
Proteins can be cleaved by the proteases that make up bromelain, which is essentially a proteolytic enzyme complex. Many active protease forms have been identified in pineapple stem extracts by research, indicating that bromelain preparations may contain many enzymatically active components.
Due to this characteristic, researchers are looking into the possibility of bromelain interacting with specific viral proteins. A new computational analysis of SARS-CoV-2 assessed potential connections between spike-protein regions involved in ACE2 binding and bromelain.
Despite conflicting clinical evidence, one of the better understood scientific fields is the potential anti-inflammatory action of bromelain. Experimental studies have investigated inflammatory mediators such as prostaglandins, TNF-α, IL-1β, IL-6, among others.
Some trials with bromelain showed an improvement in inflammatory markers in a systematic review of random clinical trials, but the overall findings were not consistent because of differences in the subjects, dosage, and duration of treatment.
Bromelain's potential to affect immune-cell activity and inflammatory signalling has been explored. In addition to anti-inflammatory and other biological functions, reviews discuss potential immunomodulatory effects.
Immune regulation, however, is complicated. An effect seen in animal models or isolated cells might not have the same effect in humans. The dosage, formulation, biological availability, and particular immune responses involved are thus still being analysed by researchers.
In suggested methods related to protein degradation and inflammation, bromelain is occasionally considered in conjunction with other proteolytic enzymes, such as nattokinase. The fact that these compounds have distinct enzymatic properties and biological activity serves as a major justification for looking into combinations.
However, claims that nattokinase and bromelain interact to eliminate spike protein shouldn't be regarded as proven clinical truth. There is currently insufficient evidence to support the combination's ability to safely and effectively produce such a result in humans. Properly designed laboratory and clinical investigations are required before firm conclusions can be drawn on any suggested synergy.
Research into Long COVID has explored several possible mechanisms behind persistent symptoms, including ongoing inflammation and altered immune responses. Bromelain has attracted scientific interest because of its proteolytic and potential anti-inflammatory properties, but research specifically connecting bromelain supplementation with Long COVID recovery remains limited.
Long COVID can involve persistent or recurring symptoms after theinitialinfection. Researchers continue to investigate why some people experience prolonged fatigue, respiratory symptoms, cognitive difficulties, and other health concerns. Understanding these mechanisms may helpidentifypotential approaches for future research.
Inflammation and abnormal immune responses are among the mechanisms being investigated in Long COVID. Studies of bromelain have reported potential effects on inflammatory markers, although results have varied between studies. A systematic review of clinical trials found that the overall anti-inflammatory effects of bromelain were inconsistent and influenced by factors such as dosage, treatment duration, and study population.
Researchers continue to examine bromelain and related enzyme-based approaches in laboratory and clinical research involving SARS-CoV-2. Some studies have investigated bromelain combinations and their effects on inflammatory responses or viral-related mechanisms in laboratory and ex-vivo settings. These findings provide areas for further investigation but do notestablishbromelain as a treatment for Long COVID.
The available evidence has important limitations. Much of the research involving bromelain and SARS-CoV-2 has been conducted in laboratory, cellular, or ex-vivo models, rather than large clinical trials specifically involving people with Long COVID. More well-designed human studies are needed todeterminewhether bromelain supplementation can provide meaningful benefits for persistent symptoms or other Long COVID outcomes.
Bromelain taken orally is described to berather safe, although the safety may vary with individual, product, dosage, and other medications. As mentioned by the United States’ National Centre for Complementary and Integrative Health, allergic reactions may occur, and some of the side effects of bromelain taken orally are indigestion and diarrhea.
There are drugs that could possibly react with bromelain. It is important to inform health care professionals regarding supplement intake, particularly when more than one drug is used. There is research showing that bromelain could possibly affect the absorption of some antibiotics like tetracyclines.
Studies conducted in the laboratory have demonstrated the fibrinolytic/antithrombotic effects of bromelain. In light of these findings, use of bromelain along with blood thinners/anti-platelets mightlead to issues related to haemorrhage. People using blood thinners are advised to seek medical advice before they consider adding bromelain supplements to their regimen.
Allergic reactions may occur because bromelain comes from pineapples, especially for those people who are allergic to pineapples or similar substances. In case you have any sensitivities, do not forget to talk to your physician before taking any supplements.
The difference between laboratory and clinical evidence is one of the most crucial factors in bromelain research. Though bromelain has been studied in humans for a variety of reasons, there is still no sufficient evidence available to make an assessment of its effectiveness in treating SARS-CoV-2 spike protein, COVID-19, and Long COVID.
Clinical trials are needed to find out the effectiveness of bromelain and to assess the appropriate dose and the population that can benefit from it.
Explore more studies and scientific papers related to bromelain, SARS-CoV-2, spike protein, and related biological mechanisms.
Molecules
Molecules
Molecules
Molecules
The information provided on this website is for educational and informational purposes only and is not intended as medical advice.
Due to its proteolytic action and its impacts on immunological and inflammatory pathways, bromelain is still a well-researched subject. Experimental research and scientific reviews serve as a foundation for evaluating the potential interactions between bromelain and proteins and inflammatory processes.
Research on spike proteins and bromelain has only recently attracted attention. Possible interactions between bromelain and SARS-CoV-2 spike-protein targets have been suggested by computational study, however these results are still in the early stages of research and do not prove a therapeutic therapy effect.
